All-cause and potentially disease-related health care costs associated with venous thromboembolism in commercial, Medicare, and Medicaid beneficiaries.

@article{Lefebvre2012AllcauseAP,
  title={All-cause and potentially disease-related health care costs associated with venous thromboembolism in commercial, Medicare, and Medicaid beneficiaries.},
  author={Patrick Lefebvre and François Lalibert{\'e} and Edith Nutescu and Mei Sheng Duh and Joyce Lamori and Brahim K. Bookhart and William H. Olson and Katherine Dea and Jeff R. Schein and Scott Kaatz},
  journal={Journal of managed care pharmacy : JMCP},
  year={2012},
  volume={18 5},
  pages={
          363-74
        }
}
BACKGROUND Patients with venous thromboembolism (VTE) are at increased risk of developing recurrent VTE and post-thrombotic syndrome (PTS), a complication of deep vein thrombosis (DVT) characterized by venous reflux and residual venous obstruction that may manifest as chronic pain and swelling. Therefore, formulary/policy decision makers should understand the clinical and economic consequences associated with VTE. OBJECTIVES To describe the real-world clinical complications, such as recurrent… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 20 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 44 REFERENCES

Risk factors for venous thromboembolism. Circulation

  • Anderson FA, FA Spencer
  • Suppl 1):I9-16. Available at: http://circ…
  • 2012

The epidemiology of venous thromboembolism. Circulation

  • RH White
  • Suppl 1):I4-8. Available at: http://circ…
  • 2012
1 Excerpt

Similar Papers

Loading similar papers…